iifl-logo-icon 1
iifl-logo-icon 1Budget 2024
iifl-logo-icon 1
Home

RPG Life Sciences Ltd Share Price

₹1,898.45
(2.69%)
Jul 23, 2024|03:32:38 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹1,848.8
  • Day's High₹1,954.55
  • 52 Wk High₹2,066
  • Prev. Close₹1,848.8
  • Day's Low₹1,808
  • 52 Wk Low ₹993
  • Turnover (lac)2,928.6
  • P/E32.9
  • Face Value₹8
  • Book Value₹242.83
  • EPS55.82
  • Mkt. Cap (Cr.)₹3,139.85
  • Div. Yield0.87
No Records Found

RPG Life Sciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹1,848.8

Prev. Close

₹1,848.8

Turnover(Lac.)

₹2,928.6

Day's High

₹1,954.55

Day's Low

₹1,808

52 Week's High

₹2,066

52 Week's Low

₹993

Book Value

₹242.83

Face Value

₹8

Mkt Cap (₹ Cr.)

3,139.85

P/E

32.9

EPS

55.82

Divi. Yield

0.87

RPG Life Sciences Ltd Corporate Action

12 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

11 Jun 2024

12:00 AM

AGM

Announcement Date: 11 Jun, 2024

arrow

30 Apr 2024

12:00 AM

Dividend

Dividend Amount: 16

Record Date: 28 Jun, 2024

arrow

RPG Life Sciences Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

RPG Life Sciences Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:24 PM
Jun-2024Mar-2024Dec-2023Sep-2023
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 72.81%

Foreign: 0.00%

Indian: 72.81%

Non-Promoter- 5.77%

Institutions: 5.77%

Non-Institutions: 21.41%

Custodian: 0.00%

Read More
Share Price

RPG Life Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

13.23

13.23

13.23

13.23

Preference Capital

0

0

0

0

Reserves

361.62

294.37

242.54

203.22

Net Worth

374.85

307.6

255.77

216.45

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

440.16

389.14

375.57

343.95

yoy growth (%)

13.11

3.61

9.19

17.13

Raw materials

-141.82

-131.1

-127.76

-114.61

As % of sales

32.22

33.68

34.01

33.32

Employee costs

-99.97

-94.66

-95.9

-90.14

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

73.17

53.58

41.77

20.36

Depreciation

-15.66

-16.47

-16.36

-14.34

Tax paid

-21.69

-13.58

-7.44

-6.91

Working capital

30

44.05

-12.51

19.51

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

13.11

3.61

9.19

17.13

Op profit growth

23.49

18.22

57.64

35.1

EBIT growth

35.53

24.93

80.13

41.53

Net profit growth

28.7

37.88

115.68

-35.98

View Ratios

No Record found

View Annually Results

RPG Life Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT RPG Life Sciences Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

H V Goenka

Independent Director

Lalit S Kanodia

Independent Director

Mahesh S Gupta

Independent Director

Manoj K Maheshwari

Company Sec. & Compli. Officer

Rajesh Shirambekar

Independent Director

Narendra Ambwani

Independent Director

Sachin Nandgaonkar

Independent Director

Zahabiya Khorakiwala

Managing Director

Yugal Sikri

Independent Director

Bhaskar Vemban Iyer

Non Executive Director

Rajat Bhargava

Independent Director

Hiten Kotak

Independent Director

Anil Matai

Independent Director

RADHIKA GUPTA

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by RPG Life Sciences Ltd

Summary

RPG Life Sciences, formerly Searle India Ltd, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The Company is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).The company is having research and development facilities that conform to international standards. It has Biotech R&D, API R&D and Formulations R&D. They are having TGA (Aus) and MHRA (UK) approved facilities at Thane in Maharashtra and Ankleshwar in Gujarat.RPG Life Sciences Ltd was incorporated on March 29, 2007 with the name RPG Pharmaceuticals Ltd. During the year 2007-08, as per the scheme of arrangement, the company acquired the pharmaceuticals business of Brabourne Enterprises Ltd along with all assets and liabilities pertaining to that business with effect from April 2, 2007 (the appointed date). In February 13, 2008, the name of the company was subsequently changed to RPG Life Sciences Ltd.During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes. They launched an oncology drug namely Exemestane. Also, they launched new products, namely Nufex Beta, Qugyl-O & Immunotec. In June 10, 2008, the equity shares of the company were listed on BSE and NSE with effect from June 10, 2008. In July 2008, the company commenced production in the new high capacity fermenters. During the year 2009-10, t
Read More

Company FAQs

What is the RPG Life Sciences Ltd share price today?

Down Arrow

The RPG Life Sciences Ltd shares price on N/A is Rs.₹1900 today.

What is the Market Cap of RPG Life Sciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of RPG Life Sciences Ltd is ₹3142.41 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of RPG Life Sciences Ltd?

Down Arrow

The PE and PB ratios of RPG Life Sciences Ltd is 32.9 and 8.10 as of 23 Jul ‘24

What is the 52 Week High and Low of RPG Life Sciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a RPG Life Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of RPG Life Sciences Ltd is ₹993.3 and ₹2057.15 as of 23 Jul ‘24

What is the CAGR of RPG Life Sciences Ltd?

Down Arrow

RPG Life Sciences Ltd's CAGR for 5 Years at 56.72%, 3 Years at 58.48%, 1 Year at 83.70%, 6 Month at 18.21%, 3 Month at 20.51% and 1 Month at 18.00%.

What is the shareholding pattern of RPG Life Sciences Ltd?

Down Arrow

The shareholding pattern of RPG Life Sciences Ltd is as follows:
Promoters - 72.81 %
Institutions - 5.77 %
Public - 21.42 %

QUICKLINKS FOR RPG Life Sciences Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.